Xu Ruhan, Yuan Wei, Wang Zhongqun
Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, China.
J Cardiovasc Transl Res. 2023 Apr;16(2):476-490. doi: 10.1007/s12265-022-10311-3. Epub 2022 Sep 6.
Glycolysis is an important way for various cells such as vascular wall endothelial cells, smooth muscle cells, macrophages, and other cells to obtain energy. In pathological conditions, it can participate in the process of AS by regulating lipid deposition, calcification, angiogenesis in plaques, etc., together with its metabolite lactic acid. Recent studies have shown that lactate-related lactylation modifications are ubiquitous in the human proteome and are involved in the regulation of various inflammatory diseases. Combined with the distribution and metabolic characteristics of cells in the plaque in the process of AS, glycolysis-lactate-lactylation modification may be a new entry point for targeted intervention in atherosclerosis in the future. Therefore, this article intends to elaborate on the role and mechanism of glycolysis-lactate-lactylation modification in AS, as well as the opportunities and challenges in targeted therapy, hoping to bring some help to relevant scholars in this field. In atherosclerosis, glycolysis, lactate, and lactylation modification as a metabolic sequence affect the functions of macrophages, smooth muscle cells, endothelial cells, lymphocytes, and other cells and interfere with processes such as vascular calcification and intraplaque neovascularization to influence the progression of atherosclerosis.
糖酵解是血管壁内皮细胞、平滑肌细胞、巨噬细胞等各类细胞获取能量的重要途径。在病理状态下,它可连同其代谢产物乳酸,通过调节脂质沉积、钙化、斑块内血管生成等过程参与动脉粥样硬化(AS)进程。近期研究表明,乳酸相关的乳酰化修饰在人类蛋白质组中广泛存在,并参与多种炎症性疾病的调控。结合AS进程中斑块内细胞的分布及代谢特征,糖酵解-乳酸-乳酰化修饰可能是未来动脉粥样硬化靶向干预的新切入点。因此,本文旨在阐述糖酵解-乳酸-乳酰化修饰在AS中的作用及机制,以及靶向治疗中的机遇与挑战,希望能为该领域的相关学者带来一些帮助。在动脉粥样硬化中,糖酵解、乳酸及乳酰化修饰作为一个代谢序列,影响巨噬细胞、平滑肌细胞、内皮细胞、淋巴细胞等细胞的功能,并干扰血管钙化和斑块内新生血管形成等过程,从而影响动脉粥样硬化的进展。